Find the Perfect Plan for Your Investment Journey
N
Latest price
52 Week Range
€0.95 - €2.59
Next Earnings Date
May 20 2025 (Estimate)
Next Earnings Date
May 20 2025 (Est.)
Latest price
Market Cap | €88.78M |
EV | €52.89M |
Shares Outstanding | 85.53M |
Beta | 0.73 |
Analyst Rating | BUY |
Analyst Target Price | €3.13 |
P/E 2025E | - |
P/Revenue 2025E | 13.20x |
Revenue | 11.60% |
EPS | 1.20% |
Operating Cash Flow | -8.40% |
Free Cash Flow | 3.20% |
Revenue | 107.60% |
EPS | 24.60% |
Operating Cash Flow | 42.60% |
Free Cash Flow | 29.70% |
Gross Margin 2025E | 85.00% |
Net Profit Margin 2025E | -287.09% |
ROE 2025E | -34.10% |
ROCE 2024 | -36.90% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
N
Nanoform Finland Oyj
NANOFH
Sector
Healthcare
Industry
Biotechnology
CEO
Haeggstrom, Edward
Employees
181
Website
www.nanoform.comIPO Date
2020-06-04
Headquarters
Cultivator II, Viikinkaari 4, Helsinki, Uusimaa, 00790, Finland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved